-+ 0.00%
-+ 0.00%
-+ 0.00%

Anixa Biosciences To Present Ovarian Cancer CAR-T Therapy Clinical Trial At 2026 SGO Annual Meeting

Benzinga·03/30/2026 13:09:26
Listen to the news

Dr. Robert Wenham of Moffitt Cancer Center and principal investigator of the trial to present lira-cel trial status

SAN JOSE, Calif., March 30, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Robert Wenham, Chair of the Gynecologic Oncology Department at Moffitt Cancer Center and principal investigator for the Company's ongoing ovarian cancer CAR-T therapy Phase 1 trial, will be presenting at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer, being held April 10 – 13, 2026, in San Juan, Puerto Rico.